Optinose Stock Investor Sentiment

OPTN Stock  USD 0.54  0.04  8.00%   
About 55% of OptiNose's investors are presently thinking to get in. The analysis of overall sentiment of trading OptiNose stock suggests that some investors are interested at this time. OptiNose's investing sentiment overview a quick insight into current market opportunities from investing in OptiNose. Many technical investors use OptiNose stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

OptiNose Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards OptiNose can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at gurufocus.com         
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
Gurufocus Stories at Macroaxis
2 days ago at bizjournals.com         
Former Optinose CEO Peter Miller comes out of retirement to launch new startup
bizjournals News
six days ago at simplywall.st         
OptiNose, Inc. Might Not Be As Mispriced As It Looks After Plunging 31
Simply Wall St News at Macroaxis
over a week ago at news.google.com         
Optinose to Announce Q3 2024 Financial Results with Investor Call - MSN
Google News at Macroaxis
over a week ago at news.google.com         
OptiNose 5-Year EBITDA Growth Rate 41.10 percent - GuruFocus.com
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
OptiNose, Inc. Just Reported, And Analysts Assigned A US3.50 Price Target
Yahoo News
over two weeks ago at simplywall.st         
Earnings Release Heres Why Analysts Cut Their OptiNose, Inc. Price Target To US3.50
Simply Wall St News at Macroaxis
over two weeks ago at simplywall.st         
OptiNose Third Quarter 2024 Earnings EPS US0.002
Simply Wall St News at Macroaxis
over two weeks ago at gurufocus.com         
FMR LLCs Strategic Acquisition of OptiNose Inc Shares
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
OptiNose Inc Q3 2024 Earnings Call Highlights Revenue Growth Amid Revised Guidance
Gurufocus Stories at Macroaxis
over two weeks ago at insidermonkey.com         
Disposition of 48225 shares by Peter Miller of OptiNose at 3.55 subject to Rule 16b-3
insidermonkey News
over two weeks ago at insidermonkey.com         
OptiNose, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at zacks.com         
OptiNose Reports Break-Even Earnings for Q3
zacks News
over two weeks ago at globenewswire.com         
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
Macroaxis News: globenewswire.com
over two weeks ago at seekingalpha.com         
OptiNose gives mixed
seekingalpha News
Far too much social signal, news, headlines, and media speculation about OptiNose that are available to investors today. That information is available publicly through OptiNose media outlets and privately through word of mouth or via OptiNose internal channels. However, regardless of the origin, that massive amount of OptiNose data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OptiNose news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OptiNose relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OptiNose's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OptiNose alpha.

OptiNose Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 4881 shares by Mahmoud Ramy A of OptiNose at 0.87 subject to Rule 16b-3
09/17/2024
2
Acquisition by Mahmoud Ramy A of 48907 shares of OptiNose subject to Rule 16b-3
09/26/2024
3
OptiNose stock hits 52-week low at 0.68 amid market challenges - Investing.com
09/30/2024
4
OptiNose Inc Q2 2024 Earnings Call Highlights Revenue Growth and Strategic Shifts Amid ...
10/09/2024
5
Disposition of 1516 shares by Marino Michael F Iii of OptiNose at 1.15 subject to Rule 16b-3
11/01/2024
6
OptiNose Inc Q3 2024 Earnings Report Preview What To Expect
11/11/2024
7
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
11/12/2024
8
OptiNose Inc Q3 2024 Earnings Call Highlights Revenue Growth Amid Revised Guidance
11/13/2024
9
Earnings Release Heres Why Analysts Cut Their OptiNose, Inc. Price Target To US3.50
11/15/2024
10
Optinose to Announce Q3 2024 Financial Results with Investor Call - MSN
11/20/2024
11
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
12/02/2024
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out OptiNose Hype Analysis, OptiNose Correlation and OptiNose Performance.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Revenue Per Share
0.553
Quarterly Revenue Growth
0.031
Return On Assets
(0.10)
Return On Equity
(10.51)
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.